EXHIBIT 10.1
SILICON VALLEY BANK
AMENDMENT AGREEMENT
BORROWER: ATS MEDICAL SALES, INC.
ATS MEDICAL, INC.
DATE: MARCH 24, 2005
THIS AMENDMENT AGREEMENT ("Amendment") is entered into between Silicon
Valley Bank ("Silicon") and the borrower named above ("Borrower"), with
reference to the following facts:
A. Silicon and Borrower are parties to that certain Loan and Security
Agreement, with an Effective Date of July 28, 2004 (as amended, the "Loan
Agreement"). (The Loan Agreement and all other present and future documents,
instruments and agreements relating thereto are referred to herein collectively
as the "Loan Documents". Capitalized terms used in this Agreement which are not
defined herein shall have the meanings set forth in the Loan Agreement.)
B. The parties desire to amend the Loan Agreement, as set forth in this
Amendment.
The parties agree as follows:
1. FINANCIAL COVENANTS. Section 6.7 of the Loan Agreement reads as
follows:
Borrower will maintain at all times, on a consolidated basis:
(i) LIQUIDITY RATIO. A ratio of (y) unrestricted cash (and
equivalents) of Borrower on deposit with Bank plus Borrower's
Eligible Accounts, (z) divided by Current Liabilities, of
equal to or greater than 2.25 to 1.00.
(ii) TANGIBLE NET WORTH. A Tangible Net Worth of at least the
following amounts for the following periods:
The Closing Date through September 30, 2004 $52,000,000
October 1, 2004 through December 31, 2004 $49,000,000
January 1, 2005 through March 31, 2005 $46,000,000
April 1, 2005 through June 30, 2005 $44,000,000
July 1, 2005 and thereafter $42,000,000
Section 6.7 of the Loan Agreement is hereby amended to read as follows,
effective as of April 1, 2005:
Borrower will maintain at all times, on a consolidated basis:
(i) LIQUIDITY RATIO. A ratio of (y) unrestricted cash (and
equivalents) of Borrower on deposit with Bank plus Borrower's
Eligible Accounts, (z) divided by Current Liabilities, of
equal to or greater than 2.00 to 1.00.
(ii) TANGIBLE NET WORTH. A Tangible Net Worth of at least the
following amounts for the following periods:
The Closing Date through September 30, 2004 $52,000,000
October 1, 2004 through December 31, 2004 $49,000,000
January 1, 2005 through March 31, 2005 $42,000,000
April 1, 2005 through June 30, 2005 $39,000,000
July 1, 2005 and thereafter $36,000,000
2. AMENDMENT FEE. In consideration for Silicon entering into this
Agreement, Borrower shall concurrently pay Silicon a fee in the amount of
$1,000, which shall be non-refundable and in addition to all interest and other
fees payable to Silicon under the Loan Documents. Silicon is authorized to
charge said fee to Borrower's loan account.
3. REPRESENTATIONS TRUE. Borrower represents and warrants to Silicon
that all representations and warranties set forth in the Loan Agreement, as
amended hereby, are true and correct.
4. GENERAL PROVISIONS. This Amendment, the Loan Agreement, any prior
written amendments to the Loan Agreement signed by Silicon and Borrower, and the
other Loan Documents set forth in full all of the representations and agreements
of the parties with respect to the subject matter hereof and supersede all prior
discussions, representations, agreements and under-standings between the parties
with respect to the subject hereof. Except as herein expressly amended, all of
the terms and provisions of the Loan Agreement, and all other Loan Documents
shall continue in full force and effect and the same are hereby ratified and
confirmed. This Amendment is part of the Loan Agreement and its terms are
incorporated herein.
BORROWER: SILICON:
ATS MEDICAL SALES, INC. SILICON VALLEY BANK
By: /s/ Xxxx X. Xxxx By: /s/ Xxxxxxx Xxxxx
Name: Xxxx X. Xxxx Title: VP Relationship Manager
Title: Chief Financial Officer
ATS MEDICAL, INC.
By: /s/ Xxxx X. Xxxx
Name: Xxxx X. Xxxx
Title: Chief Financial Officer
